+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point of Care Testing Market - Global Forecast 2026-2032- Product Image
Point of Care Testing Market - Global Forecast 2026-2032- Product Image
Sale

Point of Care Testing Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968870
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Point of Care Testing Market is projected to reach USD 41.99 Billion in 2026. It is expected to continue growing at a CAGR of 13.61%, reaching USD 90.76 Billion by 2032.

Point of care testing (POCT) is reshaping diagnostics by moving clinically actionable results closer to patients in hospitals, clinics, retail pharmacies, ambulances, workplaces, and homes. The category spans blood glucose monitoring, infectious disease testing, cardiac markers, coagulation, blood gas and electrolyte testing, pregnancy and fertility testing, urinalysis, and emerging molecular and multiplex diagnostic platforms.

Demand is supported by well-documented pressures on health systems, including aging populations, rising chronic disease prevalence, antimicrobial resistance, decentralized care models, and the need for faster clinical decisions. Regulatory oversight from agencies such as the U.S. Food and Drug Administration and frameworks such as Clinical Laboratory Improvement Amendments, the European Union In Vitro Diagnostic Regulation, and World Health Organization essential diagnostics guidance continue to shape quality, safety, access, and adoption.

Transformative Shifts in the POCT Landscape

The POCT landscape is shifting from single-analyte, operator-dependent devices toward connected, quality-controlled, and data-integrated diagnostic ecosystems. Laboratories and care networks increasingly evaluate point of care devices not only for speed, but also for analytical performance, interoperability, cybersecurity, operator training, traceability, and total cost of ownership.

COVID-19 accelerated public familiarity with rapid testing and demonstrated the operational value of decentralized diagnostics for triage, surveillance, and continuity of care. At the same time, reimbursement scrutiny, supply-chain resilience, and stricter in vitro diagnostic regulations are pushing manufacturers to validate performance across diverse populations and real-world settings. The competitive focus is moving toward platforms that combine usability, connectivity, quality assurance, and clinically meaningful turnaround time.

Cumulative Impact of Artificial Intelligence in POCT

Artificial intelligence is increasingly influencing point of care testing through automated image interpretation, signal analysis, decision support, quality monitoring, and workflow optimization. AI-enabled readers can help reduce subjectivity in lateral flow test interpretation, improve pattern recognition in digital microscopy, and flag anomalous results, device drift, or operator errors when paired with connected device data.

The cumulative impact is not only faster interpretation but also more consistent performance at distributed testing sites. However, AI adoption in POCT depends on transparent validation, bias assessment, clinical governance, cybersecurity, human oversight, and compliance with evolving medical device software regulations. Industry leaders must treat AI as a regulated clinical capability rather than a marketing layer.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America remains a mature point of care testing environment, supported by high healthcare spending, CLIA-waived testing pathways in the United States, chronic disease management programs, emergency care demand, and wide access through urgent care and retail health settings. Europe is shaped by decentralized care priorities, aging populations, antimicrobial stewardship, and the EU IVDR, which raises evidence expectations for diagnostic manufacturers and strengthens the role of post-market surveillance. Asia-Pacific is expanding through hospital modernization, infectious disease surveillance, diabetes management, aging-related care, and broader primary care access across China, India, Japan, Australia, South Korea, and ASEAN economies.

Latin America shows rising demand for rapid infectious disease, pregnancy, and chronic disease testing, although reimbursement variability, infrastructure gaps, and uneven laboratory access affect adoption. Middle East markets benefit from hospital investment, national health transformation programs, digital health initiatives, and demand for rapid emergency diagnostics. Africa relies heavily on POCT for HIV, malaria, tuberculosis, maternal health, antimicrobial stewardship, and outbreak response, with adoption tied to affordability, supply continuity, training, power reliability, and connectivity in low-resource settings.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Across G7 countries, point of care testing adoption is closely linked to value-based care, emergency department efficiency, chronic disease monitoring, antimicrobial stewardship, and regulatory emphasis on evidence and quality systems. The European Union is strongly influenced by IVDR implementation, procurement standards, laboratory governance, and cross-border healthcare priorities, increasing the importance of clinical evidence, post-market surveillance, and interoperable reporting.

BRICS economies are important demand centers because of large patient populations, public health screening needs, infectious disease burdens, and expanding domestic diagnostic manufacturing. ASEAN countries are prioritizing primary care access, maternal and child health, noncommunicable disease management, and infectious disease readiness, while GCC markets are investing in high-acuity hospital infrastructure, emergency medicine, and digital health transformation. NATO members also emphasize deployable diagnostics for military medicine, emergency preparedness, field triage, and resilient health security systems.

Key Country Insights Across Major POCT Markets

The United States leads through broad clinical use of CLIA-waived tests, retail health expansion, decentralized testing models, and FDA-regulated diagnostic innovation, while Canada emphasizes access across large geographies, remote care delivery, and provincial health system integration. Mexico and Brazil show sustained demand for affordable rapid tests in public and private care, especially for infectious diseases, pregnancy testing, and chronic disease monitoring. In Europe, the United Kingdom, Germany, France, Italy, and Spain prioritize hospital efficiency, primary care access, chronic disease management, antimicrobial stewardship, and compliance with stricter IVD rules, while Russia maintains demand for localized diagnostics and distributed healthcare access across broad territories.

In Asia-Pacific, China is expanding domestic diagnostic capacity, hospital-based testing, infectious disease surveillance, and chronic disease management; India relies on POCT to extend access across tiered healthcare settings, rural clinics, pharmacies, and public health programs; and Japan emphasizes quality, aging-related care, emergency diagnostics, and advanced testing technologies. Australia supports POCT in remote and Aboriginal health services, emergency care, and chronic disease programs, while South Korea combines strong diagnostics manufacturing, hospital digitalization, and connected healthcare adoption.

Actionable Recommendations for POCT Industry Leaders

Industry leaders should prioritize clinically validated point of care testing platforms that demonstrate accuracy, usability, connectivity, traceability, and measurable workflow impact. Product strategies should align with real care pathways such as emergency triage, antimicrobial stewardship, diabetes management, cardiovascular risk assessment, respiratory infection testing, maternal health, and remote patient monitoring.

Manufacturers should invest in interoperability with electronic health records, operator lockout and quality control features, cybersecurity, data governance, and cloud-based fleet management. Commercial teams need region-specific evidence packages that address reimbursement, procurement, regulatory requirements, training capacity, and public health priorities. Partnerships with laboratories, pharmacies, primary care networks, hospitals, public health agencies, and telehealth providers can accelerate adoption while maintaining governance, quality, and clinical accountability.

Research Methodology

This executive summary is based on secondary research and analytical synthesis from publicly available, authoritative sources, including health agency guidance, regulatory frameworks, peer-reviewed literature, clinical practice trends, international health system priorities, and public health programs. Key reference points include FDA oversight of in vitro diagnostics and medical device software, CLIA requirements, EU IVDR implementation, WHO diagnostics guidance, and global initiatives addressing infectious diseases, chronic disease management, and decentralized care.

Insights were evaluated through a market-structure lens covering clinical need, technology readiness, regulatory requirements, procurement behavior, geographic access, health system infrastructure, quality assurance, and competitive differentiation. No unverified market-size figures, market share claims, or unsupported growth forecasts are used.

Conclusion

Point of care testing is becoming a core component of modern diagnostics because it reduces time to clinical action, supports decentralized care, improves triage, and strengthens disease surveillance. Its value is highest when speed is matched by analytical reliability, connected data capture, quality controls, operator training, and clear clinical protocols.

The next phase of POCT competition will favor organizations that integrate validated assays, AI-enabled interpretation, secure connectivity, interoperable reporting, and region-specific commercialization strategies. Stakeholders that balance innovation with regulatory rigor, affordability, and real-world usability will be best positioned to serve hospitals, community care, public health, emergency medicine, and home-based testing environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Point of Care Testing Market, by Product
7.1. Introduction
7.2. Consumables Services & Software
7.2.1. Consumables & Accessories
7.2.2. Service Maintenance & Calibration
7.2.3. Software & Connectivity
7.3. Instruments & Analyzers
7.3.1. Benchtop Analyzers
7.3.2. Molecular Platforms
7.3.3. Portable Analyzers
7.3.4. Readers & Scanners
7.4. Reagents & Assays
7.4.1. Glucose Test Strips
7.4.2. Hematology Reagents
7.4.3. Immunoassay Reagents
7.4.4. Lateral Flow Assay Reagents
7.4.5. Molecular Assay Kits
8. Point of Care Testing Market, by Test Type
8.1. Introduction
8.2. Blood Gases
8.3. Cardiac Markers
8.3.1. B-type Natriuretic Peptide
8.3.2. Troponin
8.4. Comprehensive Metabolic Panel
8.5. Drug Of Abuse Testing
8.6. Hematology
8.6.1. Coagulation Tests
8.6.1.1. Activated Partial Thromboplastin Time
8.6.1.2. Fibrinogen Level
8.6.1.3. Prothrombin Time & International Normalized Ratio
8.6.2. Complete Blood Count
8.7. Infectious Disease
8.7.1. Gastrointestinal Infection Tests
8.7.2. Respiratory Infection Tests
8.7.3. Sexually Transmitted Infection Tests
8.8. Molecular Diagnostics
8.9. Pregnancy & Fertility
8.10. Urinalysis
9. Point of Care Testing Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Nasal & Swab Samples
9.4. Saliva
9.5. Urine
10. Point of Care Testing Market, by Technology
10.1. Introduction
10.2. Biosensor Electrochemical
10.3. Colorimetric Platforms
10.4. Immunoassay
10.5. Lateral Flow Assays
10.5.1. Antibody Tests
10.5.2. Antigen Tests
10.5.3. Multiplex Lateral Flow
10.6. Microfluidics
10.7. PCR And Molecular
11. Point of Care Testing Market, by Portability
11.1. Introduction
11.2. Benchtop Fixed Analyzers
11.3. Portable Handheld Devices
12. Point of Care Testing Market, by Mode of Purchase
12.1. Introduction
12.2. Over-The-Counter Tests
12.3. Prescription-Based Tests
13. Point of Care Testing Market, by Application
13.1. Introduction
13.2. Chronic Disease Management
13.3. Emergency And Critical Care
13.4. Infectious Disease Diagnosis
13.5. Occupational And Workplace Testing
13.6. Oncology Monitoring
13.7. Women Health
14. Point of Care Testing Market, by End User
14.1. Introduction
14.2. Ambulatory Care Centers
14.3. Diagnostic Laboratories
14.4. Free-Standing Emergency Departments
14.5. Home Care
14.6. Hospitals & Clinics
14.7. Urgent Care Centers
15. Point of Care Testing Market, by Distribution Channel
15.1. Introduction
15.2. Offline
15.2.1. Direct Sales
15.2.2. Distributor & Wholesale
15.2.3. Retail & Pharmacy
15.3. Online
16. Point of Care Testing Market, by Region
16.1. Asia-Pacific
16.2. North America
16.3. Latin America
16.4. Europe
16.5. Middle East
16.6. Africa
17. Point of Care Testing Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Point of Care Testing Market, by Country
18.1. United States
18.2. Germany
18.3. China
18.4. United Kingdom
18.5. India
18.6. Japan
18.7. Russia
18.8. Brazil
18.9. Canada
18.10. Italy
18.11. Mexico
18.12. France
18.13. Spain
18.14. Australia
18.15. South Korea
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. FPNV Positioning Matrix, 2025
19.3. Market Concentration Analysis, 2025
19.3.1. Concentration Ratio (CR)
19.3.2. Herfindahl Hirschman Index (HHI)
19.4. Recent Developments & Impact Analysis, 2025
19.5. Product Portfolio Analysis, 2025
19.6. Benchmarking Analysis, 2025
20. Company Profiles
20.1. Abaxis, Inc. by Zoetis Inc
20.2. Abbott Laboratories
20.3. AccuBioTech Co., Ltd.
20.4. ACON Laboratories, Inc.
20.5. Beckman Coulter
20.6. Becton, Dickinson and Company
20.7. Bio-Rad Laboratories, Inc.
20.8. bioMérieux SA
20.9. CardioGenics Holdings Inc.
20.10. Chembio Diagnostic Systems, Inc. by Biosynex
20.11. Danaher Corporation
20.12. EKF Diagnostics Holdings
20.13. F. Hoffmann-La Roche Ltd
20.14. GE Healthcare Technologies, Inc.
20.15. Medtronic Plc
20.16. Nova Biomedical Corporation
20.17. OraSure Technologies, Inc.
20.18. Quidel Corporation
20.19. Radiometer Medical ApS
20.20. Randox Laboratories Ltd.
20.21. Siemens Healthineers AG
20.22. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL POINT OF CARE TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL POINT OF CARE TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 29. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. GLOBAL POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 31. GLOBAL POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL POINT OF CARE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES SERVICES & SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES SERVICES & SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES SERVICES & SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SERVICE MAINTENANCE & CALIBRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SERVICE MAINTENANCE & CALIBRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SERVICE MAINTENANCE & CALIBRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SOFTWARE & CONNECTIVITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SOFTWARE & CONNECTIVITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SOFTWARE & CONNECTIVITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL BENCHTOP ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL BENCHTOP ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL BENCHTOP ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MOLECULAR PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PORTABLE ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL READERS & SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL READERS & SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL READERS & SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL REAGENTS & ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL REAGENTS & ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL REAGENTS & ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL GLUCOSE TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL HEMATOLOGY REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL HEMATOLOGY REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HEMATOLOGY REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL IMMUNOASSAY REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNOASSAY REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOASSAY REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL LATERAL FLOW ASSAY REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL LATERAL FLOW ASSAY REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL LATERAL FLOW ASSAY REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MOLECULAR ASSAY KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MOLECULAR ASSAY KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MOLECULAR ASSAY KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD GASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BLOOD GASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD GASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CARDIAC MARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CARDIAC MARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CARDIAC MARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL B-TYPE NATRIURETIC PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL B-TYPE NATRIURETIC PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL B-TYPE NATRIURETIC PEPTIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TROPONIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TROPONIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TROPONIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL COMPREHENSIVE METABOLIC PANEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL COMPREHENSIVE METABOLIC PANEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL COMPREHENSIVE METABOLIC PANEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL COAGULATION TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL COAGULATION TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL COAGULATION TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TIME MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TIME MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TIME MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL FIBRINOGEN LEVEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL FIBRINOGEN LEVEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL FIBRINOGEN LEVEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL COMPLETE BLOOD COUNT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL COMPLETE BLOOD COUNT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL COMPLETE BLOOD COUNT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL GASTROINTESTINAL INFECTION TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GASTROINTESTINAL INFECTION TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GASTROINTESTINAL INFECTION TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY INFECTION TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY INFECTION TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY INFECTION TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL SEXUALLY TRANSMITTED INFECTION TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL SEXUALLY TRANSMITTED INFECTION TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL SEXUALLY TRANSMITTED INFECTION TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PREGNANCY & FERTILITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PREGNANCY & FERTILITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PREGNANCY & FERTILITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL URINALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL URINALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL URINALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL NASAL & SWAB SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL NASAL & SWAB SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL NASAL & SWAB SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL URINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL URINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL BIOSENSOR ELECTROCHEMICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL BIOSENSOR ELECTROCHEMICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL BIOSENSOR ELECTROCHEMICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL COLORIMETRIC PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL COLORIMETRIC PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL COLORIMETRIC PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ANTIBODY TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ANTIBODY TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ANTIBODY TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL ANTIGEN TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL ANTIGEN TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL ANTIGEN TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL MULTIPLEX LATERAL FLOW MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL MULTIPLEX LATERAL FLOW MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL MULTIPLEX LATERAL FLOW MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL MICROFLUIDICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL PCR AND MOLECULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL PCR AND MOLECULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL PCR AND MOLECULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL BENCHTOP FIXED ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL BENCHTOP FIXED ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL BENCHTOP FIXED ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL PORTABLE HANDHELD DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL OVER-THE-COUNTER TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL OVER-THE-COUNTER TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL OVER-THE-COUNTER TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL PRESCRIPTION-BASED TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL PRESCRIPTION-BASED TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL PRESCRIPTION-BASED TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL EMERGENCY AND CRITICAL CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL EMERGENCY AND CRITICAL CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL EMERGENCY AND CRITICAL CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL OCCUPATIONAL AND WORKPLACE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL OCCUPATIONAL AND WORKPLACE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL OCCUPATIONAL AND WORKPLACE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL ONCOLOGY MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL ONCOLOGY MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL ONCOLOGY MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL WOMEN HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL WOMEN HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL WOMEN HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 188. GLOBAL FREE-STANDING EMERGENCY DEPARTMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 189. GLOBAL FREE-STANDING EMERGENCY DEPARTMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL FREE-STANDING EMERGENCY DEPARTMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 194. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 195. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL URGENT CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL URGENT CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL URGENT CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 201. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 202. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 203. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 204. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 207. GLOBAL DISTRIBUTOR & WHOLESALE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL DISTRIBUTOR & WHOLESALE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. GLOBAL DISTRIBUTOR & WHOLESALE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 210. GLOBAL RETAIL & PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL RETAIL & PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. GLOBAL RETAIL & PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 214. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 216. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2017-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2017-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 236. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 237. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 238. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 239. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 240. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 241. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 242. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 243. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 244. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2017-2032 (USD MILLION)
TABLE 245. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 246. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 247. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 248. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2017-2032 (USD MILLION)
TABLE 249. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 250. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 251. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 254. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 255. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 256. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 257. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 258. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 259. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 260. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 261. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 262. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 263. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2017-2032 (USD MILLION)
TABLE 264. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 265. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 266. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 267. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2017-2032 (USD MILLION)
TABLE 268. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 269. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 270. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 273. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 274. EUROPE POINT OF CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 275. EUROPE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 276. EUROPE POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 277. EUROPE POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 278. EUROPE POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 279. EUROPE POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 280. EUROPE POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 281. EUROPE POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 282. EUROPE POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2017-2032 (USD MILLION)
TABLE 283. EUROPE POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 284. EUROPE POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 285. EUROPE POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 286. EUROPE POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2017-2032 (USD MILLION)
TABLE 287. EUROPE POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 288. EUROPE POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 289. EUROPE POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 290. EUROPE POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 291. EUROPE POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 292. EUROPE POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 293. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 294. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 295. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 296. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 297. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 298. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 299. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 300. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 301. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2017-2032 (USD MILLION)
TABLE 302. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 303. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 304. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 305. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2017-2032 (USD MILLION)
TABLE 306. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 307. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 308. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 310. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 311. MIDDLE EAST POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 312. AFRICA POINT OF CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 313. AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 314. AFRICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 315. AFRICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 316. AFRICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 317. AFRICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 318. AFRICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 319. AFRICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 320. AFRICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2017-2032 (USD MILLION)
TABLE 321. AFRICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 322. AFRICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 323. AFRICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 324. AFRICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2017-2032 (USD MILLION)
TABLE 325. AFRICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 326. AFRICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 327. AFRICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 328. AFRICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. AFRICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 330. AFRICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 331. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 332. ASEAN POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 333. ASEAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 334. ASEAN POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 335. ASEAN POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 336. ASEAN POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 337. ASEAN POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 338. ASEAN POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 339. ASEAN POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 340. ASEAN POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2017-2032 (USD MILLION)
TABLE 341. ASEAN POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2017-2032 (USD MILLION)
TABLE 342. ASEAN POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 343. ASEAN POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 344. ASEAN POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2017-2032 (USD MILLION)
TABLE 345. ASEAN POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2017-2032 (USD MILLION)
TABLE 346. ASEAN POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2017-2032 (USD MILLION)
TABLE 347. ASEAN POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 348. ASEAN POINT OF CARE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 349. ASEAN POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 350. ASEAN POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 351. GCC POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 352. GCC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 353. GCC POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2017-2032 (USD MILLION)
TABLE 354. GCC POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2017-2032 (USD MILLION)
TABLE 355. GCC POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2017-2032 (USD MILLION)
TABLE 356. GCC POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 357. GCC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2017-2032 (USD MILLION)
TABLE 358. GCC POI

Companies Mentioned

  • Abaxis, Inc. by Zoetis Inc
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • CardioGenics Holdings Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Danaher Corporation
  • EKF Diagnostics Holdings
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Technologies, Inc.
  • Medtronic Plc
  • Nova Biomedical Corporation
  • OraSure Technologies, Inc.
  • Quidel Corporation
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 41.99 Billion
Forecasted Market Value ( USD ) by 2032 $ 90.76 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Point-Of-Care Or Rapid Diagnostics Market - Global Forecast 2026-2032 - Product Image

Point-Of-Care Or Rapid Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Point of Care Blood Testing Product Market - Global Forecast 2026-2032 - Product Image

Point of Care Blood Testing Product Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Point-of-Care/Rapid Diagnostics - Global Strategic Business Report - Product Image

Point-of-Care/Rapid Diagnostics - Global Strategic Business Report

  • Report
  • 448 Pages
  • Global
From
Point-of-Care Infectious Disease Diagnostics - Global Strategic Business Report - Product Image

Point-of-Care Infectious Disease Diagnostics - Global Strategic Business Report

  • Report
  • 287 Pages
  • Global
From
Point-of-Care Diagnostics Market Size, Share, Trends and Forecast by Product Type, Platform, Prescription Mode, End-User, and Region, 2026-2034 - Product Image

Point-of-Care Diagnostics Market Size, Share, Trends and Forecast by Product Type, Platform, Prescription Mode, End-User, and Region, 2026-2034

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.